The global cell separation market size was valued at USD 9.74 billion in 2024 and is projected to reach from USD 10.69 ...
Hosted on MSN20h
Sanofi’s Sarclisa combo approved in China for multiple myelomaSanofi has received China’s National Medical Products Administration (NMPA) approval for the use of Sarclisa (isatuximab), ...
Franke James, QUOI MediaYou degenerate, you!I am a rebel, but I have never considered myself a "degenerate." Yet, this word ...
A new platform for studying neuroinflammatory diseases, utilizing advanced 3D bioprinting technology has been developed.
Researchers have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors.
Understanding how tumors change their metabolism to resist treatments is a growing focus in cancer research. As cancer cells adapt to therapies, their metabolism often shifts, which can help them ...
News Medical on MSN23h
Researchers develop model to identify tumor-fighting immune cells in lung cancer patientsResearchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy have developed a computer model to help scientists identify tumor-fighting immune cells in ...
A Boston-area biopharmaceutical firm has submitted a biologics license application to the FDA for its investigational, fully ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback